NT-proBNP for Heart Failure Treatment Decisions and Monitoring Response

NT-proBNP levels can guide heart failure therapy decisions and monitor treatment response, with serial measurements tracking whether drug adjustments are improving cardiac function.

Richards, Mark et al.·European journal of heart failure·2004·Moderate EvidenceReview
RPEP-00965ReviewModerate Evidence2004RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

NT-proBNP serves as both a diagnostic tool and a treatment monitoring biomarker in heart failure, with serial measurements guiding drug titration and tracking therapeutic response for personalized care.

Key Numbers

How They Did This

review study on natriuretic-peptides, cardiovascular.

Why This Research Matters

Relevant for natriuretic-peptides, cardiovascular, clinical-trials.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding NT-proBNP serves as both a diagnostic tool and a treatment monitoring biomarker in heart failure, with serial measurements guiding drug titration and
Evidence Grade:
moderate evidence.
Study Age:
Published in 2004.
Original Title:
NT-proBNP in heart failure: therapy decisions and monitoring.
Published In:
European journal of heart failure, 6(3), 351-4 (2004)
Database ID:
RPEP-00965

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

NT-proBNP for Heart Failure Treatment Decisions and Monitoring Response

What was found?

NT-proBNP levels can guide heart failure therapy decisions and monitor treatment response, with serial measurements tracking whether drug adjustments are improving cardiac function.

Read More on RethinkPeptides

Cite This Study

RPEP-00965·https://rethinkpeptides.com/research/RPEP-00965

APA

Richards, Mark; Troughton, Richard W. (2004). NT-proBNP in heart failure: therapy decisions and monitoring.. European journal of heart failure, 6(3), 351-4.

MLA

Richards, Mark, et al. "NT-proBNP in heart failure: therapy decisions and monitoring.." European journal of heart failure, 2004.

RethinkPeptides

RethinkPeptides Research Database. "NT-proBNP in heart failure: therapy decisions and monitoring..." RPEP-00965. Retrieved from https://rethinkpeptides.com/research/richards-2004-ntprobnp-in-heart-failure

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.